Klinik und Poliklinik für Geburtshilfe und Frauengesundheit
Klinikum / Johannes Gutenberg-Universität Mainz
Heitz, Florian; Amant, Frederic; Fotopoulou, Christina et al.
Synchronous Ovarian and Endometrial Cancer-an International Multicenter Case-Control StudyINTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER. Bd. 24. H. 1. 2014 S. 54-60
Gomez, Ruth; Schorsch, Martin; Steetskamp, Joscha et al.
The effect of ovarian stimulation on the outcome of intrauterine inseminationARCHIVES OF GYNECOLOGY AND OBSTETRICS. Bd. 289. H. 1. 2014 S. 181-185
Witzel, Isabell; Graeser, Monika; Karn, Thomas et al.
Androgen receptor expression is a predictive marker in chemotherapy-treated patients with endocrine receptor-positive primary breast cancersJOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY. Bd. 139. H. 5. 2013 S. 809-816
Rodriguez-Lescure, A.; Brase, J. C.; Schmidt, M. et al.
Biomarkers for predicting taxane efficacy in ER+/HER2-breast cancer patients: From in-vitro chemosensitivity screening to clinical validation in the GEICAM/ 9906 trialEUROPEAN JOURNAL OF CANCER. Bd. 49. 2013 S. S475-S475
Barinoff, J.; Traut, A.; Bauerschlag, D. et al.
Chemotherapy for 70-Year-Old Women with Breast Cancer in Germany: A Survey by the German Breast GroupGEBURTSHILFE UND FRAUENHEILKUNDE. Bd. 73. H. 5. 2013 S. 433-439
Dubsky, P.; Filipits, M.; Jakesz, R. et al.
EndoPredict improves the prognostic classification derived from common clinical guidelines in ER-positive, HER2-negative early breast cancerANNALS OF ONCOLOGY. Bd. 24. H. 3. 2013 S. 640-647
Maass, Nicolai; Harbeck, Nadia; Mundhenke, Christoph et al.
Everolimus as treatment for breast cancer patients with bone metastases only: results of the phase II RADAR studyJOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY. Bd. 139. H. 12. 2013 S. 2047-2056
Schmidt, M.
Gene expression signatures in breast cancerONKOLOGE. Bd. 19. H. 6. 2013 S. 465-+
Schmidt, M.
Genexpressionssignaturen beim MammakarzinomOnkologe. Bd. 19. 2013 S. 465-470
von Minckwitz, Gunter; Moebus, Volker; Schneeweiss, Andreas et al.
German Adjuvant Intergroup Node-Positive Study: A Phase III Trial to Compare Oral Ibandronate Versus Observation in Patients With High-Risk Early Breast CancerJOURNAL OF CLINICAL ONCOLOGY. Bd. 31. H. 28. 2013 S. 3531-3539